PTCA後のアンギナ痛の特徴の変化は,レステノシスではなく,異なる動脈の狭窄を示唆しています
1Istituto di Cardiologia, Università Cattolica del S. Cuore, Rome, Italy.
Circulation
|December 13, 1997
まとめ
静脈痛の位置の変化は,血管新生手術 (PTCA) の後の新冠動脈狭窄を示す可能性があります. 異なる痛みの位置は,治療された動脈のリステノシスではなく,新しい阻害を示唆します.
科学分野:
- 心臓病学 心臓病学
- 介入性心臓病学 介入性心臓病学
- クリニカル・メディシン 臨床医学
背景:
- 以前の研究では,心臓発作の痛みの位置が,多発性心筋梗塞と関連していた.
- 同じ地域で2回の心臓発作を起こした患者は,同様の痛みパターンを報告した.
研究 の 目的:
- 変異した門痛の位置が,皮膚経冠動脈血管形成術 (PTCA) の後の新冠動脈狭窄と再狭窄を識別できるかどうかを判断する.
主な方法:
- 単血管疾患のPTCA後の再発症状を有する38人の患者を研究した.
- 冠動脈動脈検査では,静止病 (n=26) または新しい静止病 (n=12) が確認されました.
- 患者は,アンギノグラフィーを繰り返す前に,アンギノ痛の位置と放射線を報告した.
主要な成果:
- 痛みの位置と狭窄部位との相関は見つかりませんでした.
- リステノス症の患者は,PTCA後の異なる痛みの位置を報告したことはありません (0%),新しい狭窄症の42%に対して (P=.002).
- 異なる疼痛放射線は,レステノシスで4%で,新しいステノシスで50%で発生しました (P=.002).
- 痛みの位置/放射線の変化は,新しい狭窄症に対して96%の特異性と58%の感度を示した.
結論:
- 異なる門痛の位置によって,新冠動脈狭窄症とPTCA後の静脈狭窄症を区別することがあります.
- 心臓の痛みの位置の変化は,新しい心筋の領域におけるイシュケミアの兆候となる可能性があります.
関連する概念動画
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...


